
Cimitidine
- Payment Type:
- L/C, T/T, D/P, Money Gram
Quantity:
Your message must be between 20 to 2000 characters
Contact NowBasic Info
Basic Info
Place of Origin: | Shenzhen, Guangdong |
---|---|
Payment Type: | L/C, T/T, D/P, Money Gram |
Product Description
Product Description
CAS No.: 51481-61-9
MF: C10H16N6S
EINECS No.: C10H16N6S
Place of Origin: China (Mainland)
Type: Gastrointestinal Agents
Grade Standard: Medicine Grade
Purity: 99%
Color: WHITE OR OF-WHITE CRYSTALLINE POWDER
Packaging & Delivery
Packaging Detail: 25kg/drum
Delivery Detail: Within two weeks after payment received
Specifications
Cimitidine/CAS No.: 51481-61-9
1. CAS No.: 51481-61-9
2. Color: White crystalline powder
3. Standard: TYPE A
4. Packing: 25kg/drum
Cimetidine INN (pron.: /smtdin/ or /samtdin/) is a histamine H2-receptor antagonist that inhibits stomach acid production. It is largely used in the treatment of heartburn and peptic ulcers. It has been marketed by GlaxoSmithKline (which is selling the brand to Prestige Brands) under the trade name Tagamet (sometimes Tagamet HB or Tagamet HB200). Cimetidine was approved in the UK in 1976 and was approved in the US by the Food and Drug Administration for prescriptions starting January 1, 1979.
MF: C10H16N6S
EINECS No.: C10H16N6S
Place of Origin: China (Mainland)
Type: Gastrointestinal Agents
Grade Standard: Medicine Grade
Purity: 99%
Color: WHITE OR OF-WHITE CRYSTALLINE POWDER
Packaging & Delivery
Packaging Detail: 25kg/drum
Delivery Detail: Within two weeks after payment received
Specifications
Cimitidine/CAS No.: 51481-61-9
1. CAS No.: 51481-61-9
2. Color: White crystalline powder
3. Standard: TYPE A
4. Packing: 25kg/drum
Cimetidine INN (pron.: /smtdin/ or /samtdin/) is a histamine H2-receptor antagonist that inhibits stomach acid production. It is largely used in the treatment of heartburn and peptic ulcers. It has been marketed by GlaxoSmithKline (which is selling the brand to Prestige Brands) under the trade name Tagamet (sometimes Tagamet HB or Tagamet HB200). Cimetidine was approved in the UK in 1976 and was approved in the US by the Food and Drug Administration for prescriptions starting January 1, 1979.
Related Keywords
Related Keywords